Loss-of-function mutations in ZIP13 lead to Ehlers-Danlos syndrome with connective tissue fragility (Fukada et al., 2008), while ZIP14-mediated zinc mislocalization has been implicated in muscle wasting and metabolic dysfunction in cancer cachexia (Wang et al., 2018). Here, SLC39A14 is linked to Ehlers-Danlos syndrome.